Can a nasal cannula replace ventilators for bronchiectasis patients?

NCT ID NCT05741697

Recruiting now Symptom relief Sponsor: Assiut University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two ways to help people with bronchiectasis breathe easier during a sudden worsening of their condition. Twenty patients in the ICU will receive either a high flow nasal cannula or non-invasive ventilation. Researchers will measure how long patients stay in the ICU and how well they tolerate the treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: high flow nasal cannula and non-invasive ventilation
What this could lead to: If this works, it could show that high flow nasal cannula is a more comfortable and equally effective alternative to traditional breathing support for bronchiectasis patients in the ICU.
What could go wrong: This is a very small early-stage trial with only 20 participants, so results may not apply to all patients. The study focuses on short-term ICU outcomes, not long-term disease control.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHIECTASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bronchiectasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRONCHIECTASIS

Contacts and locations

Locations

Assiut University-Faculty of medicine
RECRUITING

Asyut, Asyut Governorate, 71515, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.